Côd QR

The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study

Background: CDK4/6 inhibitors combined with endocrine therapy have significantly improved treatment outcomes for metastatic hormone receptor-positive (HR+) breast cancer patients. However, the impact of low HER2 expression on treatment response and progression-free survival (PFS) remains unclear. Me...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Eda Caliskan Yildirim, Elif Atag, Ezgi Coban, Olcun Umit Unal, Abdussamet Celebi, Murat Keser, Mehmet Uzun, Merve Keskinkilic, Eda Tanrikulu Simsek, Murat Sari, Tugba Yavuzsen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2023-08-01
Cyfres:Breast
Pynciau:
HER2-Low
ribociclib
palbociclib
hormone positive
breast cancer
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S0960977623005106
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg